SIM
ARIA

Spark Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Spark Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-126,700
Closed -$809K – 922
2016
Q1 		$809K Buy
126,700
+36,600
+41% +$205K 0.08% 339
2015
Q4 		$563K Buy
+90,100
New +$591K 0.07% 351

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Spark Investment Management's ARIA Position: Q2 2016 in Review

Spark Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2016, closing a stake of 126,700 shares — an estimated $809K sold.

Spark Investment Management first reported a position in ARIA in Q4 2015 and held it in 2 quarters. The position peaked at $809K in Q1 2016. 182 funds tracked by Wall St. Rank hold ARIA as of Q2 2016.

  • Spark Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Spark Investment Management sold 126,700 Ariad Pharmaceuticals Inc shares in Q2 2016, an estimated $809K.
  • Spark Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 2 quarters.
  • Spark Investment Management's Ariad Pharmaceuticals Inc position peaked at $809K in Q1 2016.
  • 182 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2016.

Based on Spark Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.